Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRX-08066 in PH-COPD
NCT00677872Phase 2Terminated
- Sponsor
- Epix Pharmaceuticals
- Start
- May 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prx-08066 in pulmonary hypertension (PH), sponsored by Epix Pharmaceuticals. Started May 2008; status: terminated.
02
Drugs
prx-08066
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT00677872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00677872.